BMJ  2007;335:929-932 (3 November), doi:10.1136/bmj.39346.696620.AE

Clinical Review

Management of sepsis

Iain Mackenzie, consultant in intensive care medicine and anaesthesia1, Andrew Lever, professor of infectious diseases and honorary consultant physician2

1 John Farman Intensive Care Unit, Box 17, Addenbrooke's Hospital, Cambridge CB2 2QQ, 2 Department of Medicine, University of Cambridge, Cambridge

Correspondence to: I Mackenzie  iain@number2.demon.co.uk

The first 150 words of the full text of this article appear below.

This is the second of two reviews—the first discussed the definition, epidemiology, and diagnosis of sepsis, whereas this one focuses on management and outcome. Management of sepsis can conveniently be divided into general supportive measures and specific treatment.


Summary points

A favourable outcome depends on early, aggressive, treatment
Antimicrobial treatment must take into account both patient susceptibilities and local resistance patterns; advice from infectious disease or microbiology colleagues is often helpful
Volume resuscitation and cardiovascular support should be titrated to simple clinical end points
Subtle signs of organ hypoperfusion should be sought in physically robust patients
The role of activated protein C and low dose steroids remains to be clarified


What are the general supportive measures?

Circulatory compromise arises from the combination of vasodilatation, capillary leak, and reduced myocardial contractility, and needs early correction. Whether crystalloids or colloids are better for volume resuscitation remains unresolved. Few people now use human albumin after a controversial meta-analysis concluded that albumin . . . [Full text of this article]

Box 1 Clinical and functional end points for titration of fluid resuscitation
Box 2 Resuscitation end points in the study by Rivers and colleagues6

What specific treatments are available?


Antimicrobials
Corticosteroids
Immunoglobulins and statins
HMGB-1

Multiple system organ failure and outcome


Box 3 Common sequence of organ failure
Primary involvement
Secondary involvement
Tertiary involvement

Conclusion


Sources and selection criteria
Tips for non-specialists
Additional educational resources
Information resources for patients

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Surviving sepsis campaign's recommendations
Lindsay E M Reid
BMJ 2007 335: 1007. [Extract] [Full Text] [PDF]

Going to extremes
Tony Delamothe
BMJ 2007 335: 0. [Extract] [Full Text]

Sepsis: definition, epidemiology, and diagnosis
Andrew Lever and Iain Mackenzie
BMJ 2007 335: 879-883. [Extract] [Full Text] [PDF]

Human albumin administration in critically ill patients: systematic review of randomised controlled trials Why albumin may not work
Cochrane Injuries Group Albumin Reviewers and Cochrane Injuries Group Albumin Reviewers
BMJ 1998 317: 235-240. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Reid, L. E M (2007). Surviving sepsis campaign's recommendations. BMJ 335: 1007-1007 [Full text]  

Rapid Responses:

Read all Rapid Responses

Diagnosis and management of sepsis - at the bedside
Lindsay EM Reid
bmj.com, 8 Nov 2007 [Full text]
Our experience in the management of sepsis
Belkys Rodriguez Llerena, et al.
bmj.com, 11 Nov 2007 [Full text]
Don’t overlook supportive therapy for sepsis
Akashdeep Singh, et al.
bmj.com, 13 Nov 2007 [Full text]
Human recombinant activated protein C for severe sepsis
Georgia Salanti, et al.
bmj.com, 16 Nov 2007 [Full text]
Steroids in sepsis
Iain D Drummond
bmj.com, 19 Nov 2007 [Full text]
Predicted, Ideal or Actual Body Weight ?
M Samer Abdalla
bmj.com, 3 Dec 2007 [Full text]
Re: Predicted, Ideal or Actual Body Weight ?
Iain M Mackenzie, et al.
bmj.com, 3 Dec 2007 [Full text]



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview